Top Healthcare Stocks
Healthcare stocks were mixed in afternoon trade with the NYSE Healthcare Sector Index falling about 0.4% and shares of healthcare companies in the S&P 500 rising about 0.1% as a group.
In company news, Achillion Pharmaceuticals ( ACHN ) was higher Friday after saying patients treated with its ACH-3102 drug candidate for hepatitis C showed no signs of the virus after four weeks during Phase II testing.
According to the company, all 12 patients taking the drug when combined with Gilead Sciences ( GILD ) Sovaldi Hep C treatment showed no detectable traces of the virus after four weeks. ACHN now plans to begin trials with 12 additional patients for six weeks with a once-daily dose of the two drugs.
ACHN shares were ahead nearly 10% at $9.25 apiece this afternoon, earlier climbing to a new 52-week high of $10.20 a share. GILD also was higher today, rising almost 3% to $99.10 a share today.
In other sector news,
(+) CRMD, FDA accepts Phase III study protocol of Neutrolin drug candidate in hemodialysis patients with a central venous catheter. Also announces strategic pact with Wonik Corp. to sell Neutrolin in South Korea after expected regulatory approval.
(-) CLRB, Prices $12.5 mln public offering of 3.33 mln shares at $3.75 apiece, as well warrants to buy additional 3.33 mln shares at $4.68 each. Issues 1.11 mln shares and warrants in exchange of cancelling $4 mln of convertible debentures.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.